Michael T. Lotze
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Cell Biology, Immunology, Genetics, OncologyGoogle:
"Michael Lotze"Children
Sign in to add traineeSiuwah Tang | grad student | 2014 | University of Pittsburgh |
Philip J. Vernon | grad student | 2014 | University of Pittsburgh |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Perales-Linares R, Leli NM, Mohei H, et al. (2023) Parkin deficiency suppresses antigen presentation to promote tumor immune evasion and immunotherapy resistance. Cancer Research |
Giehl E, Kosaka H, Liu Z, et al. (2021) Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy. Frontiers in Immunology. 12: 610042 |
Soloff AC, Jones KE, Powers AA, et al. (2020) HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions. Frontiers in Immunology. 11: 2027 |
Allen A, Gau D, Francoeur P, et al. (2020) Actin-binding protein Profilin1 promotes aggressiveness of clear cell renal cell carcinoma cells. The Journal of Biological Chemistry |
Dhupar R, Okusanya OT, Eisenberg SH, et al. (2020) Characteristics of Malignant Pleural Effusion Resident CD8 T Cells from a Heterogeneous Collection of Tumors. International Journal of Molecular Sciences. 21 |
Huang J, Chen P, Liu K, et al. (2020) CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. Gut |
Zhang X, Deibert CP, Kim WJ, et al. (2020) Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era. Cancer Gene Therapy |
Guo ZS, Lotze MT, Zhu Z, et al. (2020) Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy. Biomedicines. 8 |
Feist M, Zhu Z, Dai E, et al. (2020) Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy. Cancer Gene Therapy |
Brufsky A, Marti JLG, Nasrazadani A, et al. (2020) Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection. Journal of Translational Medicine. 18: 261 |